GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Shiller PE Ratio

HLB Therapeutics Co (XKRX:115450) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HLB Therapeutics Co Shiller PE Ratio Historical Data

The historical data trend for HLB Therapeutics Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Shiller PE Ratio Chart

HLB Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HLB Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HLB Therapeutics Co's Shiller PE Ratio

For the Biotechnology subindustry, HLB Therapeutics Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Therapeutics Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Shiller PE Ratio falls into.



HLB Therapeutics Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

HLB Therapeutics Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, HLB Therapeutics Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.126/118.8477*118.8477
=2.126

Current CPI (Mar. 2024) = 118.8477.

HLB Therapeutics Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 11.669 99.353 13.959
201409 -14.936 99.608 -17.821
201412 -33.538 99.098 -40.222
201503 -93.818 99.720 -111.814
201506 -20.537 100.050 -24.396
201509 -19.137 100.110 -22.719
201512 -27.072 100.220 -32.104
201603 -22.871 100.560 -27.030
201606 -18.670 100.790 -22.015
201609 -27.072 101.460 -31.711
201612 -42.475 101.560 -49.705
201703 -39.674 102.850 -45.845
201706 -14.936 102.610 -17.300
201709 -27.539 103.490 -31.626
201712 -20.071 102.990 -23.161
201803 -18.670 104.100 -21.315
201806 -15.403 104.130 -17.580
201809 198.371 105.650 223.151
201812 -70.480 104.350 -80.272
201903 -35.007 104.490 -39.817
201906 -47.609 104.880 -53.949
201909 -35.940 105.200 -40.603
201912 -205.372 105.120 -232.192
202003 -13.069 105.540 -14.717
202006 -129.758 104.870 -147.053
202009 -60.211 106.200 -67.382
202012 -110.154 105.765 -123.779
202103 -42.942 107.357 -47.538
202106 -108.287 107.579 -119.630
202109 -39.674 108.759 -43.354
202112 -106.887 109.676 -115.825
202203 -29.406 111.806 -31.258
202206 -14.003 114.083 -14.588
202209 -45.593 114.831 -47.188
202212 -96.969 115.200 -100.039
202303 -17.391 116.550 -17.734
202306 43.478 117.140 44.112
202309 -13.797 119.111 -13.766
202312 -57.459 118.848 -57.459
202403 2.126 118.848 2.126

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HLB Therapeutics Co  (XKRX:115450) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


HLB Therapeutics Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines